Preview Mode Links will not work in preview mode


Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of precision medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age-related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Dec 4, 2017

Marty Driscoll, CEO of Spring Bank Pharmaceuticals, discusses treatments for the hepatitis B virus, a disease suffered by 250 million people globally who are chronically infected with the hepatitis B virus. Marty talks about what a functional cure for chronically infected patients means, and what Spring Bank is doing to help those affected. Spring Bank is developing a new oral drug named inarigivir that is a selective immunomodulator/encapsidation inhibitor. Inarigivir could become a key component of a future safe and simple combination treatment in an effort to substantially increase functional cure rates for patients with chronic hepatitis B and reduce their need for daily drugs.


#HBV #HepatitisB  #Functionalcure #inarigivir

Spring Bank Pharmaceuticals